Correlation Between Haleon Plc and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Haleon Plc and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haleon Plc and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Haleon plc and Sangamo Therapeutics, you can compare the effects of market volatilities on Haleon Plc and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haleon Plc with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haleon Plc and Sangamo Therapeutics.
Diversification Opportunities for Haleon Plc and Sangamo Therapeutics
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Haleon and Sangamo is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Haleon plc and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Haleon Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haleon plc are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Haleon Plc i.e., Haleon Plc and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between Haleon Plc and Sangamo Therapeutics
Considering the 90-day investment horizon Haleon Plc is expected to generate 12.98 times less return on investment than Sangamo Therapeutics. But when comparing it to its historical volatility, Haleon plc is 10.16 times less risky than Sangamo Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Sangamo Therapeutics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 57.00 in Sangamo Therapeutics on September 2, 2024 and sell it today you would earn a total of 169.00 from holding Sangamo Therapeutics or generate 296.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Haleon plc vs. Sangamo Therapeutics
Performance |
| Timeline |
| Haleon plc |
| Sangamo Therapeutics |
Haleon Plc and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Haleon Plc and Sangamo Therapeutics
The main advantage of trading using opposite Haleon Plc and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haleon Plc position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.| Haleon Plc vs. Tff Pharmaceuticals | Haleon Plc vs. Eliem Therapeutics | Haleon Plc vs. Inhibrx | Haleon Plc vs. Enliven Therapeutics |
| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |